CDC Director Approves Booster Dose of Pfizer COVID-19 Vaccine for Older Adults, At-Risk Workers

Posted by Argentum on September 24, 2021

This morning, CDC Director Rochelle Walensky endorsed Pfizer COVID-19 vaccine booster shots for people 65 years of age and older and residents in long-term care settings, as well as people 18 years of age and older with underlying medical conditions. Additionally, she approved boosters for those over 18 who are at increased risk due to an occupational or institutional setting. While we are waiting for official guidance from the CDC, it should be noted that OSHA’s definition of high-risk workplaces includes those working in assisted living and continuing care retirement communities and as such, those employees could be covered under this endorsement.

Read More

Topics: Vaccine

FDA Authorizes Booster Dose of Pfizer COVID-19 Vaccine for Those 65+

Posted by Argentum on September 23, 2021

Last night, the U.S. Food and Drug Administration made an amendment to the Emergency Use Authorization (EUA) for the Pfizer COVID-19 vaccine allowing for a booster dose to be given at least six months after completion of its primary series in those 65 years of age and older. They also authorized the booster for those 18+ who are at high risk of severe COVID-19 and those whose occupations put them at risk, such as "health care workers, teachers and day care staff, grocery workers and those in homeless shelters or prisons, among others,” said acting FDA Commissioner Dr. Janet Woodcock.

Read More

Topics: Vaccine

FDA Expert Panel Recommends Pfizer Booster Dose for Those 65 and Older

Posted by Argentum on September 17, 2021

Today, the FDA’s Vaccines and Related Biological Products Advisory Committee met and voted unanimously to recommend Emergency Use Authorization (EUA) for a booster dose of the Pfizer COVID-19 vaccine to be given six months after full vaccination for those 65 and older and those at high risk of severe illness due to COVID-19. They also informally suggested that health care workers be considered for the booster dose.

Read More

Topics: Vaccine

FDA Gives Full Approval to Pfizer COVID-19 Vaccine

Posted by Argentum on August 23, 2021

Today, the U.S. Food & Drug Administration (FDA) fully approved the Pfizer-BioNTech COVID-19 vaccine, which will now be marketed as Comirnaty, for the prevention of COVID-19 in those 16 years of age and older.

Read More

Topics: Vaccine

Stay Tuned: COVID-19 Booster Vaccinations Ahead for Residents, Staff

Posted by Argentum on August 19, 2021

Wednesday, the CDC issued a joint statement with other federal regulatory agencies on plans for an additional booster dose of the Pfizer or Moderna mRNA COVID-19 vaccines. Need for a booster with the Johnson & Johnson vaccine is still being evaluated.

Read More

Topics: Vaccine, Guidance

CDC Releases New Mask Guidance for Fully Vaccinated People

Posted by Argentum on July 27, 2021

The CDC updated its mask guidance today for people who are fully vaccinated in the general public. Guidance for healthcare professionals remains unchanged at this time. The CDC now recommends wearing a mask indoors in any of these conditions:

Read More

Topics: Vaccine, Guidance

Now Open: Provider Relief Fund Reporting Portal

Posted by Argentum on July 1, 2021

As of today, July 1, the Provider Relief Fund (PRF) Reporting Portal is now open. Providers that received one or more payments exceeding $10,000, in the aggregate, during a Payment Received Period are required to report on the use of funds. PRF recipients must only use payments for eligible expenses, including services rendered, and lost revenues attributable to coronavirus before the deadline that corresponds to the relevant Payment Received Period. Providers who are required to report during Reporting Period 1 have until September 30, 2021 to enter the Portal and submit their information. All recipients of PRF payments must comply with the reporting requirements described in the Terms and Conditions.

Access PRF Reporting Portal
Read More

Topics: Funding

CDC Publishes Updated Guidance for Fully Vaccinated Residents, Workers in Assisted Living

Posted by Argentum on April 28, 2021

Yesterday, the CDC published updated guidance calling for prioritization of visitation, dining, and a re-opening of group activities in assisted living communities. This guidance, which also includes recommendations for discontinuation of routine testing for asymptomatic staff, follows a series of discussions where Argentum advocated for such guidance specifically for the assisted living sector. We thank those at the CDC for listening to the industry's needs and for the volunteers at Argentum for sharing their expertise in helping to shape this guidance.

“This is tremendously welcome news for residents and families who’ve long awaited meaningful engagement with each other," said James Balda, Argentum president & CEO. "Both visitation and dining are core socialization activities at our communities; lifting restrictions for those fully vaccinated will continue to support social enrichment for residents and families. We are thankful that resident vaccination rates across the industry are exceedingly high and that a sense of normalcy is returning. At Argentum, we are continuing to work closely with the CDC to ensure further guidance is adapted for assisted living and other senior living communities.”
Read More

Topics: Testing, Resident Engagement, Visitation

Expiration Date Extended on BinaxNOW Tests

Posted by Argentum on April 16, 2021

Users of the BinaxNOW™ COVID-19 Ag Card are urged to check the lot numbers and expiration dates of their tests. Abbott has informed users that further testing has authorized use of some tests up to nine months, three months beyond the original expiration dates.

Read More

Topics: Testing

Argentum Releases Visitation Guidance for Vaccinated Senior Living Communities

Posted by Argentum on March 26, 2021

Visitation is essential to the health and well-being of senior living residents. Argentum's latest guidance, "Model Visitation Protocols For Vaccinated Senior Living Communities," provides protocols, considerations, and general practices designed specifically for visitation in the variety of spaces and circumstances in senior living communities. This guidance was compiled by clinical experts, risk managers, and other stakeholders who have in-depth knowledge of senior living. 

Download Your Copy
Read More

Topics: Vaccine, Visitation

Subscribe to Instant Email Updates

See More COVID-19 Announcements

Read more announcements related to COVID-19 on our Coronavirus Blog and access more information on:

SEE BLOG

Stay Updated on COVID-19

Find all of our latest updates on developments related to COVID-19 on our Coronavirus Toolkit.

SEE TOOLKIT